智通财经APP讯，归创通桥(02190)发布公告，截至2025年12月31日止年度(报告期间)的本公司权益持有人应占溢利净额预期将超过人民币2.4亿元，较截至2024年12月31日止年度的人民币1.003亿元同比增长约 139.4%;及报告期间的本集团收入预期将超过人民币10.5亿元，较截至2024年12月31日止年度的人民币7.8亿元同比增加约34.6%。
业绩显著改善主要由于三大因素推动： 1) 多款旗舰产品的国内销售持续强劲增长，包括麒麟血流导向装置、神经血管导丝、UltraFree药物洗脱PTA球囊扩张导管(UltraFree DCB)及Swan静脉腔内射频闭合导管; 2) 由于我们成功于多个地区拓展市场，国际销售同比增长超过100%;及 3) 相对稳定的毛利率，加上持续提升的营运效率。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.